L293-0147 Screening compound: N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzene-1-sulfonamide

L293-0147 Screening compound: N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzene-1-sulfonamide
L293-0147 Screening compound: N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L293-0147
N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L293-0147

Molecular Formula

C19H24N4O6S (C19 H24 N4 O6 S)

Compound Name

N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzene-1-sulfonamide

IUPAC name

N-(2-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-2-methyl-5-(5-methyl-124-oxadiazol-3-yl)benzene-1-sulfonamide

SMILES

Cc1nc(-c2cc(S(NCC(N(CC3)CCC33OCCO3)=O)(=O)=O)c(C)cc2)no1

InChI

InChI=1S/C19H24N4O6S/c1-13-3-4-15(18-21-14(2)29-22-18)11-16(13)30(25,26)20-12-17(24)23-7-5-19(6-8-23)27-9-10-28-19/h3-4,11,20H,5-10,12H2,1-2H3

InChI Key

ZWYOOOGPHZQJBD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15123060

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.49

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.484

Distribution Coefficient, logD

1.476

Water Solubility, LogSw

-2.51

Polar Surface Area

103.731

Acid Dissociation Constant (pKa)

9.13

Base Dissociation Constant (pKb)

-0.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.60

L293-0147 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L293-0147 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L293-0147?
Check Price and Availability of L293-0147, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L293-0147 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L293-0147
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L293-0147
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L293-0147 available by request